These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26242226)

  • 1. The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.
    Pansieri C; Pandolfini C; Bonati M
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1159-64. PubMed ID: 26242226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency.
    Krleža-Jeriç K; Lemmens T; Reveiz L; Cuervo LG; Bero LA
    Rev Panam Salud Publica; 2011 Jul; 30(1):87-96. PubMed ID: 22159656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
    Hirsch L
    Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials transparency and access to anonymized individual participant data.
    Dal-Ré R
    Rev Psiquiatr Salud Ment; 2017; 10(1):1-3. PubMed ID: 27986414
    [No Abstract]   [Full Text] [Related]  

  • 6. Registering clinical trials.
    Dickersin K; Rennie D
    JAMA; 2003 Jul; 290(4):516-23. PubMed ID: 12876095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moving toward the reduction of publication/reporting biases in clinical trials using a new international standard].
    Doi Y
    Nihon Koshu Eisei Zasshi; 2016; 63(10):599-605. PubMed ID: 27773897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding disclosure of conflicts of interest: the views of stakeholders.
    Brody BA; Anderson C; McCrary SV; McCullough L; Morgan R; Wray N
    IRB; 2003; 25(1):1-8. PubMed ID: 12833897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Registries for clinical trials -- a critical stock-taking].
    Bestehorn K; Hönig R; Clemens N; Kirch W
    Med Klin (Munich); 2006 Feb; 101(2):120-6. PubMed ID: 16501909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trials, Healthy Controls, and the Birth of the IRB.
    Stark L; Greene JA
    N Engl J Med; 2016 Sep; 375(11):1013-5. PubMed ID: 27626515
    [No Abstract]   [Full Text] [Related]  

  • 11. 2017, a key year on clinical trials transparency.
    Dal-Ré R
    Med Clin (Barc); 2018 Jan; 150(2):80-81. PubMed ID: 28864090
    [No Abstract]   [Full Text] [Related]  

  • 12. Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Interim final rule with request for comments.
    Department of Health and Human Services (HHS)
    Fed Regist; 2005 Feb; 70(22):5543-65. PubMed ID: 15690579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with results reporting at ClinicalTrials.gov.
    Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
    N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Registration of clinical trials: a statement from the International Committee of Medical Journal Editors].
    DeAngelis C; Drazen JM; Frizelle FA; Haug C; Hoey J; Horton R; Kotzin S; Laine C; Marusic A; Overbeke AJ; Schroeder TV; Sox HC; van der Weyden MB;
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1870-1. PubMed ID: 15497781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.
    Bleicher EW
    Food Drug Law J; 2009; 64(3):531-64. PubMed ID: 19999642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues surrounding women and minorities in drug trials.
    Wermeling DP; Selwitz AS
    Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2012.
    Rawal B; Deane BR
    Curr Med Res Opin; 2015; 31(7):1431-5. PubMed ID: 25942525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public registration of clinical trials.
    Steinbrook R
    N Engl J Med; 2004 Jul; 351(4):315-7. PubMed ID: 15269307
    [No Abstract]   [Full Text] [Related]  

  • 20. Questions of scientific responsibility: the Baltimore case.
    Lang S
    Ethics Behav; 1993; 3(1):3-72. PubMed ID: 11653082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.